These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21463969)

  • 1. Moderate toxic effects following acute zonisamide overdose.
    Hofer KE; Trachsel C; Rauber-Lüthy C; Kupferschmidt H; Kullak-Ublick GA; Ceschi A
    Epilepsy Behav; 2011 May; 21(1):91-3. PubMed ID: 21463969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of adjunctive zonisamide therapy for refractory partial seizures.
    Baulac M; Leppik IE
    Epilepsy Res; 2007 Jul; 75(2-3):75-83. PubMed ID: 17553670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zonisamide: new drug. No advantage in refractory partial epilepsy.
    Prescrire Int; 2007 Jun; 16(89):95-7. PubMed ID: 17582922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction to zonisamide.
    Baulac M
    Epilepsy Res; 2006 Feb; 68 Suppl 2():S3-9. PubMed ID: 16413170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of United States and European clinical trials of zonisamide in the treatment of refractory partial-onset seizures.
    Faught E
    Seizure; 2004 Dec; 13 Suppl 1():S59-65; discussion S71-2. PubMed ID: 15511695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lacosamide intoxication in attempted suicide.
    Bauer S; David Rudd G; Mylius V; Hamer HM; Rosenow F
    Epilepsy Behav; 2010 Apr; 17(4):549-51. PubMed ID: 20171144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures.
    Brodie MJ; Duncan R; Vespignani H; Solyom A; Bitenskyy V; Lucas C
    Epilepsia; 2005 Jan; 46(1):31-41. PubMed ID: 15660766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term safety and efficacy of zonisamide in patients with refractory partial-onset epilepsy.
    Wroe SJ; Yeates AB; Marshall A
    Acta Neurol Scand; 2008 Aug; 118(2):87-93. PubMed ID: 18547272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence against a significant implication of carbonic anhydrase inhibitory activity of zonisamide in its anticonvulsive effects.
    Masuda Y; Noguchi H; Karasawa T
    Arzneimittelforschung; 1994 Mar; 44(3):267-9. PubMed ID: 8192690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.
    Shinnar S; Pellock JM; Conry JA
    Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zonisamide as adjunctive therapy for refractory partial seizures.
    Brodie MJ
    Epilepsy Res; 2006 Feb; 68 Suppl 2():S11-6. PubMed ID: 16316744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot study of zonisamide (1,2-benzisoxazole-3-methanesulfonamide) in patients with refractory partial seizures.
    Sackellares JC; Donofrio PD; Wagner JG; Abou-Khalil B; Berent S; Aasved-Hoyt K
    Epilepsia; 1985; 26(3):206-11. PubMed ID: 3924586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zonisamide concentrations during pregnancy.
    Oles KS; Bell WL
    Ann Pharmacother; 2008 Jul; 42(7):1139-41. PubMed ID: 18577760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, controlled clinical trial of zonisamide as adjunctive treatment for refractory partial seizures.
    Sackellares JC; Ramsay RE; Wilder BJ; Browne TR; Shellenberger MK
    Epilepsia; 2004 Jun; 45(6):610-7. PubMed ID: 15144425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flexible dosing of adjunctive zonisamide in the treatment of adult partial-onset seizures: a non-comparative, open-label study (ZEUS).
    Dupont S; Striano S; Trinka E; Springub J; Giallonardo AT; Smith P; Ellis S; Yeates A; Baker G
    Acta Neurol Scand; 2010 Mar; 121(3):141-8. PubMed ID: 20047564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zonisamide for the treatment of epilepsy.
    Arzimanoglou A; Rahbani A
    Expert Rev Neurother; 2006 Sep; 6(9):1283-92. PubMed ID: 17009916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zonisamide in the management of epilepsy--Japanese experience.
    Ohtahara S
    Epilepsy Res; 2006 Feb; 68 Suppl 2():S25-33. PubMed ID: 16321507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zonisamide prophylaxis in refractory pediatric headache.
    Pakalnis A; Kring D
    Headache; 2006 May; 46(5):804-7. PubMed ID: 16643584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zonisamide for migraine prophylaxis in refractory patients.
    Ashkenazi A; Benlifer A; Korenblit J; Silberstein SD
    Cephalalgia; 2006 Oct; 26(10):1199-202. PubMed ID: 16961786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zonisamide and associated oligohidrosis and hyperthermia.
    Low PA; James S; Peschel T; Leong R; Rothstein A
    Epilepsy Res; 2004 Nov; 62(1):27-34. PubMed ID: 15519129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.